AQ

Adrian Quartel

Chief Medical Officer at KemPharm

Adrian Quartel has a diverse work experience spanning several years. Adrian is currently working as the Chief Medical Officer at Zevra Therapeutics since January 2024. Prior to this, they served as the Chief Medical Officer at Acer Therapeutics Inc. from February 2022 to January 2024, and at Adamas Pharmaceuticals, Inc. from September 2020 to February 2022.

Before their roles as Chief Medical Officer, Adrian held various positions at BioMarin Pharmaceutical Inc., including Group Vice President, Head Global Medical Affairs from June 2017 to September 2020, Vice President, Medical Affairs, Americas from February 2016 to June 2017, and Executive Medical Director, Global Medical Affairs from April 2012 to February 2016. Adrian also worked as Senior Director Medical Affairs EUMEA from March 2011 to March 2012 and as Medical Director Europe Middle East and Africa from July 2007 to March 2011.

Adrian's earlier positions include the role of Medical Director UK at Chiltern int from July 2006 to July 2007, European Medical Affairs Manager at Astellas Pharma from November 2003 to July 2006, Senior Clinical Research Physician at ICON Clinical Research from September 2001 to November 2003, and Clinical Research Coordinator at California Clinical Trials from January 2000 to September 2001.

Their career started at Erasmus MC where they worked as an SHO Thoracic Surgery from December 1998 to November 1999. Prior to that, Adrian worked as a Research Fellow at Cedars-Sinai Medical Center from February 1996 to December 1998.

Adrian Quartel obtained a Doctor of Medicine (M.D.) degree in medicine from Erasmus University Rotterdam in the years 1988-1996. Later, they pursued further education at the Royal College of Physicians from 2006-2012, specializing in Pharmaceutical Medicine. Additionally, Adrian attained the title of Fellow Faculty Of Pharmaceutical Medicine from the Faculty of Pharmaceutical Medicine. There is also a mention of Adrian attending Cardiff University / Prifysgol Caerdydd from 2004-2006, but the field of study or degree attained is not specified.

Links

Previous companies

BioMarin Pharmaceutical logo
Erasmus MC logo
Cedars-Sinai logo
ICON logo

Timeline

  • Chief Medical Officer

    January, 2024 - present

View in org chart